RNAi

Gene Info

  • Species: Human (Homo sapiens)
  • GeneID: 23511
  • Symbol: NUP188
  • Description: nucleoporin 188
DataSource: http://genomernai.dkfz.de/v16/genedetails/23511

Export (tab separated) Export to Excel
Stable_ID Entrez_ID Gene_ID Gene_Symbol Reagent_ID Score Phenotype Conditions Follow_Up Comment Screen_Title Publication_Title Authors Publication_Year Pubmed_ID Biosource Biomodel Assay Method Library Scope Reagent_Type Score_Type Cutoff Notes
GR00098-A-1 23511 ENSG00000095319 NUP188 ENSG00000095319 sp none no Cell division (1) Genome-scale RNAi profiling of cell division in human tissue culture cells. Kittler et al. 2007 17994010 Cell line HeLa Cell number and DNA content Laser scanning cytometry rp Genome-wide esiRNA Complex, sp Complex criteria
GR00151-A-1 23511 ENSG00000095319 NUP188 np 0.116 none no Homologous recombination DNA double-strand break repair (HR-DSBR) (1) A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. SÅ‚abicki et al. 2010 20613862 Cell line HeLa (HR-DSBR) DR-GFP reporter Flow cytometry Custom-made Genome-wide esiRNA Z-score < -2 OR > 2
GR00196-A-1 23511 ENSG00000095319 np sp none no TP53 interactions (1) A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly. Krastev et al. 2011 21642980 Cell line HCT116 ( wildtype and TP53 knockout) TP53 protein expression and viability Fluorescence rp Genome-wide esiRNA Complex, sp Complex criteria
GR00209-A-1 23511 NM_015354, XM_497078 NUP188 np np none yes Ribosome biogenesis (1) A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60S subunit export. Wild et al. 2010 21048991 Cell line HeLa Rps2 protein expression Fluorescence np Selected genes siRNA Average relative rank from > > 0.2
GR00209-A-2 23511 NM_015354, XM_497078 NUP188 np np none yes Ribosome biogenesis (2) A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60S subunit export. Wild et al. 2010 21048991 Cell line HeLa Enp1 protein expression Fluorescence np Selected genes siRNA Complex, sp Complex criteria
GR00209-A-3 23511 NM_015354, XM_497078 NUP188 np np none no Ribosome biogenesis (3) A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60S subunit export. Wild et al. 2010 21048991 Cell line HeLa Rpl29 protein expression Fluorescence np Selected genes siRNA Average relative rank from > > 0.25
GR00249-S 23511 23511 NUP188 J-032297-09 -0.82536 none no number of cells compared to control (%): 98.41 Vaccinia virus (VACV) infection Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Sivan et al. 2013 23401514 Cell line HeLa Vaccinia virus VACV IHD-J/GFP protein expression and DNA content Fluorescence Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus Genome-wide siRNA Z-score > Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %.
GR00249-S 23511 23511 NUP188 M-032297-01 -1.95123 Decreased vaccinia virus (VACV) infection no number of cells compared to control (%): 52.20 Vaccinia virus (VACV) infection Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Sivan et al. 2013 23401514 Cell line HeLa Vaccinia virus VACV IHD-J/GFP protein expression and DNA content Fluorescence Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus Genome-wide siRNA Z-score > Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %.
GR00249-S 23511 23511 NUP188 s23964 0.0058 none no number of cells compared to control (%): 73.46 Vaccinia virus (VACV) infection Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Sivan et al. 2013 23401514 Cell line HeLa Vaccinia virus VACV IHD-J/GFP protein expression and DNA content Fluorescence Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus Genome-wide siRNA Z-score > Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %.
GR00249-S 23511 23511 NUP188 s23965 -0.24984 none no number of cells compared to control (%): 91.75 Vaccinia virus (VACV) infection Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Sivan et al. 2013 23401514 Cell line HeLa Vaccinia virus VACV IHD-J/GFP protein expression and DNA content Fluorescence Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus Genome-wide siRNA Z-score > Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %.
GR00249-S 23511 23511 NUP188 s23966 -1.06109 none no number of cells compared to control (%): 92.49 Vaccinia virus (VACV) infection Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Sivan et al. 2013 23401514 Cell line HeLa Vaccinia virus VACV IHD-J/GFP protein expression and DNA content Fluorescence Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus Genome-wide siRNA Z-score > Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %.
GR00251-A-1 23511 NUP188 np -1 Decreased shRNA abundance Non-small cell lung cancer (NSCLC) cytotoxicity (1) Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. Cron et al. 2013 24040035 Cell line A549 shRNA abundance Microarray np Genome-wide shRNA Complex, sp Complex criteria All listed genes are final hits. Final hit: >
GR00251-A-2 23511 NUP188 np -1 Decreased shRNA abundance Non-small cell lung cancer (NSCLC) cytotoxicity (2) Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. Cron et al. 2013 24040035 Cell line NCI-H460 shRNA abundance Microarray np Genome-wide shRNA Complex, sp Complex criteria All listed genes are final hits. Final hit: >
GR00255-A-1 23511 23511 NUP188 TRCN0000130400, TRCN0000146357, TRCN0000146975, TRCN0000149292 -0.051030598 none Negative genetic interactions (1) A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. Vizeacoumar et al. 2013 24104479 Cell line HCT116 shRNA abundance Microarray np Genome-wide shRNA differential Gene Activity Ranking Profile (dGARP) < -1.0 HCT116 BLM-/- and HCT116 BLM+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells)
GR00255-A-2 23511 23511 NUP188 TRCN0000130400, TRCN0000146357, TRCN0000146975, TRCN0000149292 -0.119797056 none Negative genetic interactions (2) A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. Vizeacoumar et al. 2013 24104479 Cell line HCT116 shRNA abundance Microarray np Genome-wide shRNA differential Gene Activity Ranking Profile (dGARP) < -1.0 HCT116 MUS81-/- and HCT116 MUS81+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells)
GR00255-A-3 23511 23511 NUP188 TRCN0000130400, TRCN0000146357, TRCN0000146975, TRCN0000149292 -0.565267092 none Negative genetic interactions (3) A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. Vizeacoumar et al. 2013 24104479 Cell line HCT116 shRNA abundance Microarray np Genome-wide shRNA differential Gene Activity Ranking Profile (dGARP) < -1.2 HCT116 PTEN-/- and HCT116 PTEN+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells)
GR00255-A-4 23511 23511 NUP188 TRCN0000130400, TRCN0000146357, TRCN0000146975, TRCN0000149292 -1.952467007 Negative genetic interaction between PTTG1-/- and PTTG1+/+ Negative genetic interactions (4) A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. Vizeacoumar et al. 2013 24104479 Cell line HCT116 shRNA abundance Microarray np Genome-wide shRNA differential Gene Activity Ranking Profile (dGARP) < -1.2 HCT116 PTTG1-/- and HCT116 PTTG1+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells)
GR00255-A-5 23511 23511 NUP188 TRCN0000130400, TRCN0000146357, TRCN0000146975, TRCN0000149292 -0.90656506 Negative genetic interaction between KRASG13D/+ and KRAS+/- Negative genetic interactions (5) A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. Vizeacoumar et al. 2013 24104479 Cell line HCT116 shRNA abundance Microarray np Genome-wide shRNA differential Gene Activity Ranking Profile (dGARP) < -0.8 HCT116 KRASG13D/- and HCT116 KRAS+/- cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells)
GR00290-A 23511 23511 NUP188 SI00663012 1 Decreased centriole number Centriole biogenesis Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells Balestra et al. 2013 23769972 Cell line HeLa Centriole number Fluorescence Qiagen Genome-wide siRNA Phenotype strength 0: none, 1: weak, 2: clear, 3: strong For alternative scores (RSA and Top2) see publication.
GR00290-A 23511 23511 NUP188 SI00663005 0 none Centriole biogenesis Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells Balestra et al. 2013 23769972 Cell line HeLa Centriole number Fluorescence Qiagen Genome-wide siRNA Phenotype strength 0: none, 1: weak, 2: clear, 3: strong For alternative scores (RSA and Top2) see publication.
GR00290-A 23511 23511 NUP188 SI00662998 1 Decreased centriole number Centriole biogenesis Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells Balestra et al. 2013 23769972 Cell line HeLa Centriole number Fluorescence Qiagen Genome-wide siRNA Phenotype strength 0: none, 1: weak, 2: clear, 3: strong For alternative scores (RSA and Top2) see publication.
GR00290-A 23511 23511 NUP188 SI00662991 2 Decreased centriole number Centriole biogenesis Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells Balestra et al. 2013 23769972 Cell line HeLa Centriole number Fluorescence Qiagen Genome-wide siRNA Phenotype strength 0: none, 1: weak, 2: clear, 3: strong For alternative scores (RSA and Top2) see publication.
GR00300-A 23511 NUP188 TRCN0000146357, TRCN0000130400, TRCN0000146975, TRCN0000149292 1 none Combinatorial effect with RAF inhibitor PLX4720 A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition. Whittaker et al. 2013 23288408 Cell line A375 shRNA abundance Sequencing TRC Genome-wide shRNA Number of shRNAs ranked Top1000 > 2 The A375 cell line used here harbours the BRAF V600E mutation and is therefore sensitive to RAF inhibitors.
GR00310-A-1 23511 23511 NUP188 np -0.15 none Sindbis virus (SINV) infection (1) Genome-Wide RNAi Screen Identifies Novel Host Proteins Required for Alphavirus Entry Ooi et al. 2013 24367265 Cell line U2OS Sindbis virus (SINV) reporter Luminescence Ambion Silencer V3 Genome-wide siRNA Z-score < -3 OR > 2
23511 23511 NUP188 np 40.6 none 78,5% viability
GR00360-A-1 23511 ENSG00000095319 NUP188 225799 1.125 Strongly decreased CFP-tsO45G cell surface transport Secretory transport (1) Genome-wide RNAi screening identifies human proteins with a regulatory function in the early secretory pathway Simpson et al. 2012 22660414 Cell line HeLa Kyoto CFP-tsO45G cell surface transport Fluorescence Ambion Genome-wide siRNA Deviation score < - 1 OR > 0.75 (mild: 0.75 - 1.0; strong: > 1.0) For validation screen see Secretory transport (2).
GR00360-A-1 23511 ENSG00000095319 NUP188 225798 0.8531000000000001 Mildly decreased CFP-tsO45G cell surface transport Secretory transport (1) Genome-wide RNAi screening identifies human proteins with a regulatory function in the early secretory pathway Simpson et al. 2012 22660414 Cell line HeLa Kyoto CFP-tsO45G cell surface transport Fluorescence Ambion Genome-wide siRNA Deviation score < - 1 OR > 0.75 (mild: 0.75 - 1.0; strong: > 1.0) For validation screen see Secretory transport (2).
GR00363-A 23511 23511 NUP188 SI00662991_1, esi1987, SI00662991, 225798, SI00662991_2, SI00662991_3, 225799 sp Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region) weak but specific Endocytosis regulation Systems survey of endocytosis by multiparametric image analysis. Collinet et al. 2010 20190736 Cell line HeLa Transferrin (TF) and epidermal growth factor (EGF) subcellular localisation, DNA content Fluorescence Ambion, Qiagen and esiRNA library (Kittler et al.) Genome-wide siRNA Complex, sp Complex criteria Two hit categories: "strong" (maximum of Prob Chi2, Prob Chi2 EGF, Prob Chi2 Tfn > 0.95) and "weak but specific" (maximum of Prob Chi2, Prob Chi2 EGF, Prob Chi2 Tfn < 0.95 but Phenoscore > 0.95). Additional information about secondary screens with kinase and phospatase libraries.
23511 23511 NUP188 0.010000000000000009 none
GR00376-A-1 23511 23511 NUP188 0.827241528 none Mitigators of SS1P-induced immunotoxicity Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity Pasetto et al. 2015 25713356 Cell line KB cells Viability Luminescence Ambion Silencer Select Version 4 Genome-wide siRNA RSA P-value <0.001 SS1P was applied in a "high dose", ≈EC90, 13 ng/ml. Cutoff was derived from data submitted to Pubchem (ID 1117281). Reagent sequences but no ID
GR00376-A-2 23511 23511 NUP188 0.083140209 none Sensitizers of SS1P-induced immunotoxicity Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity Pasetto et al. 2015 25713356 Cell line KB cells Viability Luminescence Ambion Silencer Select Version 4 Genome-wide siRNA RSA P-value <0.001 SS1P was applied in a "low dose", ≈EC30, 3 ng/ml. Cutoff was derived from data submitted to PubChem (ID 1117281). Reagent sequences but no ID
GR00378-A 23511 NUP188 -0.900171353 none Poliovirus vaccine production Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game van der Sanden et al. 2015 26581994 Cell line HEp-2C Infection with Attenuated Poliovirus ELISA Dharmacon Genome-wide siRNA Z-score > For infection, a single lot of the attenuated Sabin type 2 poliovirus was used for the screen. Gene IDs were not provided, only the gene name/symbol
GR00386-A-1 23511 23511 NUP188 70.0035869744355 none NOD2 stimulation by MDP A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. Warner et al. 2014 25170077 Cell line HEK293 stably expressing NOD2 Viability Luminescence Dharmacon Genome-wide siRNA Percentage growth Decreased: <70, increased: >120 Reagent IDs not provided
GR00386-A-2 23511 23511 NUP188 -104.1 none MDP-induced IL-8 secretion A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. Warner et al. 2014 25170077 Cell line HEK293 stably expressing NOD2 IL-8 secretion ELISA Dharmacon Genome-wide siRNA Percent inhibition of IL-8 secretion Increased: <-300, Decreased: >60 Concentration of IL-8 was measured from cell supernatants by sandwich ELISA. IL-8 values (pg/ml) were normalized to IL-8 secreted in cells treated with RIPK2-specific siRNA (100% inhibition) and non-targeting siRNA (0% inhibition). Secondary validating screen assessed 554 genes whose silencing affected MDP-induced IL-8 secretion in the primary screen. Final validated IL-8 regulators (positive or negative) are listed in the comments column. Reagent IDs not provided